Product NDC: | 0002-1200 |
Proprietary Name: | Amyvid |
Non Proprietary Name: | Florbetapir F 18 |
Active Ingredient(s): | 51 mCi/mL & nbsp; Florbetapir F 18 |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0002-1200 |
Labeler Name: | Eli Lilly and Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA202008 |
Marketing Category: | NDA |
Start Marketing Date: | 20120601 |
Package NDC: | 0002-1200-10 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 CAN (0002-1200-10) > 10 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 0002-1200-10 |
Proprietary Name | Amyvid |
Package Description | 1 VIAL, MULTI-DOSE in 1 CAN (0002-1200-10) > 10 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 0002-1200 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Florbetapir F 18 |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120601 |
Marketing Category Name | NDA |
Labeler Name | Eli Lilly and Company |
Substance Name | FLORBETAPIR F-18 |
Strength Number | 51 |
Strength Unit | mCi/mL |
Pharmaceutical Classes | Radioactive Diagnostic Agent for Positron Emission Tomography [EPC],Positron Emitting Activity [MoA] |